Researcher
Ruth Van Daele
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Oct 2017 → 30 Sep 2022
Projects
1 - 2 of 2
- Mold-active Azoles: Development, Validation and Implementation of strategies for Safe and Effective Dosing (M-ADVISED)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Clinical validation of antifungal dosing strategies in critically ill patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
Publications
1 - 10 of 24
- Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation(2022)
Authors: Beatrijs Mertens, Ruth Van Daele, Yves Debaveye, Joost Wauters, Christophe Vandenbriele, Matthias Gijsen
Pages: 3526 - 3527 - Liposomal amphotericin B exposure in critically ill patients: a prospective pharmacokinetic study(2022)
Authors: Ruth Van Daele, Joost Wauters, Omar Elkayal, Erwin Dreesen, Yves Debaveye, Katrien Lagrou, Johan Maertens
- The impact of extracorporeal membrane oxygenation on the exposure to isavuconazole: a plea for thorough pharmacokinetic evaluation(2022)
Authors: Joost Wauters, Yves Debaveye, Greet Hermans, Christophe Vandenbriele, Ruth Van Daele
- Meropenem Target Attainment and Population Pharmacokinetics in Critically Ill Septic Patients with Preserved or Increased Renal Function(2022)
Authors: Matthias Gijsen, Omar Elkayal, Pieter Annaert, Ruth Van Daele, Yves Debaveye, Joost Wauters, Erwin Dreesen, Isabel Spriet
Pages: 53 - 62 - Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study(2022)
Authors: Ruth Van Daele, Joost Wauters, Erwin Dreesen, Lore Vanderbeke, Isabel Spriet
Pages: 656 - 660 - Isavuconazole in the Treatment of Aspergillus fumigatus Fracture-Related Infection: Case Report and Literature Review(2022)
Authors: Beatrijs Mertens, Ruth Van Daele, Melissa Depypere, Katrien Lagrou, Yves Debaveye, Joost Wauters, Stefaan Nijs, Willem-Jan Metsemakers, Isabel Spriet
- Interaction between flucloxacillin and azoles: Is isavuconazole next?(2021)
Authors: Ruth Van Daele, Joost Wauters, Christophe Vandenbriele, Katrien Lagrou, Robin Vos, Yves Debaveye
Pages: 1508 - 1511 - Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapy(2021)
Authors: Ruth Van Daele, Greet De Vlieger, Dirk Kuypers, Yves Debaveye
Pages: 3322 - 3325 - Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid(2021)
Authors: Ruth Van Daele, Joost Wauters, Matthias Gijsen, Pieter Annaert, Yves Debaveye, Katrien Lagrou, Willy Peetermans
- Pharmacokinetic variability and target attainment of fluconazole in critically ill patients(2021)
Authors: Ruth Van Daele, Joost Wauters, Katrien Lagrou, Matthias Gijsen, Yves Debaveye